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Prenatal Phthalate Exposure and Later  
Child Behavior
Human exposure to phthalates is ubiquitous due to widespread 
commercial use. Although the compounds are reported to be rap­
idly metabolized, concentrations in the body appear to remain fairly 
stable due to ongoing exposure. The United States and Europe have 
banned some phthalates from consumer products primarily on the 
basis of reproductive toxicity data. However, not all phthalates are 
regulated; meanwhile, research indicates toxicity may extend to 
other endocrine targets such as the thyroid gland, which is critical for 
proper neurodevelopment. A new study now reports an association 
between prenatal exposure to certain phthalates and adverse effects 
on test scores used to evaluate children’s behavior and executive 
functioning  [EHP 118:565–571; Engel et al.].
The prospective study was based on a multi­
ethnic cohort of 404 women recruited dur­
ing their first pregnancy for the Mount Sinai 
Children’s Environmental Health Study between 
1998 and 2002. Each woman completed medi­
cal, sociodemographic, and lifestyle question­
naires and provided a urine sample between 
25 and 40 weeks of pregnancy, which was used to 
measure phthalate metabolites. Metabolites were 
grouped according to their molecular weights.  
When their children were approximately 
4.5–5.5, 6–6.5, and 7–9 years old, 188 of the 
women completed the Behavior Rating Inventory 
of Executive Functioning (BRIEF) and the 
Behaviors Assessment System for Children­
Parent Rating Scales (BASC­PRS), standardized 
forms used in clinical and research assessments 
of children’s executive functioning and behav­
ior. Executive functions encompass planning to 
achieve goals, controlling attention and emotion, 
inhibiting inappropriate behaviors, and extrapolating from life experi­
ences. Problematic behaviors assessed included hyper  activity, aggres­
sion, poor conduct, and issues with anxiety, attention, and adaptability.
High­molecular­weight phthalates—like those found in medical 
tubing and vinyl floor and wall coverings—were not associated with 
altered scores derived from the parent­report forms aside from a small 
association with reduced emotional control. However, low­molecular­
weight phthalates—like those found in personal care products such 
as perfume, shampoo, cosmetics, and nail polish—were significantly 
associated with increased scores for aggression, attention and conduct 
problems, and depression. 
The BASC­PRS includes a scale to help researchers weed out 
inaccurate assessments. The higher the resulting F-score, the more 
likely the assessment is to reflect an excessively negative evaluation 
of the child, a failure to follow instructions, random responding, or 
difficulty reading. When parent­report forms were restricted to those 
with F-scores of 0 or 1 (leaving 161 children in 
the analyses), most associations remained strong 
for boys but not girls. The sole exception was 
conduct problems, which remained significant for 
both girls and boys.
The behavioral problems assessed in this study 
are relevant to conditions such as oppositional defi­
ant disorder, conduct disorder, and attention defi­
cit/hyperactivity disorder. Diagnosing these condi­
tions requires extensive testing beyond the scope of 
this study. Furthermore, this study cannot confirm 
that phthalate exposure caused these problems via 
altered thyroid function—or any other mechanism. 
However, thyroid­related phthalate toxicity makes 
a connection biologically plausible and underscores 
an urgent need to further investigate the effects of 
phthalates on neurodevelopment. 
Julia R. Barrett, MS, ELS, a Madison, WI–based science writer 
and editor, has written for EHP since 1996. She is a member of the 
National Association of Science Writers and the Board of Editors in 
the Life Sciences.
ToxCast on Target
In Vitro Assays and Computer Modeling Show 
Promise for Screening Chemicals
Government agencies rely on toxicity data to help make key regula­
tory decisions on pesticides and other chemicals in the environment. 
But thousands of chemicals, including many currently in commerce, 
have yet to be tested for potential toxicity and impact on human 
diseases. Such testing can be time­consuming and expensive; a 
full set of regulatory tests for a single chemical may use thousands 
of animals and cost millions of dollars. To help address this large 
backlog of untested chemicals, the U.S. Environmental Protection 
Agency (EPA) recently completed the first phase of its large­scale 
ToxCast™ program, which looks at the potential for combining faster 
and less expensive in vitro assays with computer modeling to screen 
and prioritize chemicals for human toxicity [EHP 118:485–493; 
Judson et al.]. This approach could both reduce the need for animal 
testing and speed up the regulatory process.
The ToxCast program evaluates the use of in vitro assays for 
understanding the types of molecular and pathway perturbations 
caused by chemical exposures and computer­based prioritization 
models for in vivo toxicity. In phase I, researchers chose 309 chemicals 
for which toxicity data were already available. Using 467 in vitro assays 
across 9 technologies, including high­throughput cell­free assays and 
cell­based assays in multiple human primary cells and cell lines, they 
investigated a broad spectrum of chemical activities at the molecular 
and pathway levels. Matching these in vitro results with existing data 
helped researchers build initial prioritization models for predicting 
toxicity of similar but untested chemicals.
This process also provided information on underlying mecha­
nisms of toxicity, which are difficult to investigate directly using 
animal models. Using human cells or human cell constituents allowed 
researchers to measure the effects of chemicals on toxicity pathways 
that may be relevant to human disease. Based on the phase I examples, 
the ToxCast researchers feel confident that in vitro high­throughput 
data can help predict mechanisms of action for many other well­
studied chemicals and indicate which other biological pathways may 
also be activated. This will lay the groundwork for screening untested 
chemicals and provide vital guidance for future testing.
The authors hope molecular and computational models will help 
better guide targeted testing of environmental contaminants but cau­
tion that building this new paradigm will itself take time and require 
input from multiple government organizations. They are launching 
a second phase of ToxCast to expand on and further confirm that 
in vitro testing can help predict human toxicity. Phase II could be 
completed over the next several years.
Rebecca Clay Haynes has written for EHP since 1993. Her work has also appeared on National 
Public Radio and in the Christian Science Monitor and The Environmental Forum. In addition, she 
is the author of two children’s science books related to astronomy and space exploration.
Low-molecular-weight phthalates are 
found in many personal care products.Chew on This
Persistent Organic Pollutants May Promote 
Insulin Resistance Syndrome
Animal studies indicate some persistent organic pollutants (POPs)   
may be endocrine disruptors and suggest similar health risks for 
humans. Recent studies have further suggested an association 
between exposure to POPs and the prevalence of type 2 diabetes. 
Now an experimental animal study reports evidence of a causal link 
between POP exposure and insulin resistance syndrome, a cluster of 
metabolic disorders—including type 2 diabetes—that are marked by 
sustained high blood sugar [EHP 118:465–471; Ruzzin et al.].
POPs accumulate in fatty tissue, where they can remain for years 
because they are not easily broken down. Fatty fish are a potential 
source of POP exposure in many human populations. However, 
n­3 polyunsaturated fatty acids in fish oil may have beneficial health 
effects, possibly including protective effects on insulin resistance, 
that could counterbalance any adverse effects of POPs in fatty fish. 
In the current study, rats were exposed for 28 days to high­fat 
diets that contained either crude fish oil (from farmed Atlantic 
salmon) or fish oil that was refined to remove POPs. As expected, 
the crude fish oil contained much higher levels of POPs than the 
refined oil. Gene expression profile comparisons of the livers of 
the 2 treatment groups showed that POP exposure disrupted lipid 
homeostasis. 
Rats on the unrefined fish oil diet gained more weight overall 
and had increased triacylglycerol, diacylglycerol, and total choles­
terol levels compared with rats fed refined fish oil. They also showed 
impaired insulin action in response to the high­fat diet, whereas the 
high­fat diet did not seem to cause insulin resistance in the rats fed 
refined fish oil. Further analysis revealed a reduction in the ability 
of insulin to stimulate glucose uptake in adipocytes treated with a 
mixture of POPs that was comparable to the mixture of chemicals in 
crude fish oil. Adipocyte responses to insulin varied with exposures 
to different mixtures of individual POPs.
The authors conclude that dietary exposure to POPs may be a 
risk factor for insulin resistance and associated metabolic disorders. 
Furthermore, the metabolic effects of POP exposures exacerbated 
deleterious effects of a high­fat diet on rats and appeared to negate 
protective effects of n­3 polyunsaturated fatty acids on insulin 
resistance.
Tanya Tillett, MA, of Durham, NC, is a staff writer/editor for EHP. She has been on the EHP staff 
since 2000 and has represented the journal at national and international conferences.
Brain Drain?
PBDEs Alter Development of Human Brain Cells
A new laboratory study demonstrating that polybrominated diphenyl 
ethers (PBDEs) can alter human fetal brain cells may explain at least 
in part the neurotoxicity recently documented in epidemiologic stud­
ies of young children exposed to PBDEs and previously shown in 
animal models [EHP 118:572–578; Schreiber et al.]. The new study, 
the first to examine PBDE neurotoxicity in a human cell–based sys­
tem, links the brain cell alterations to endocrine disruption.
A wealth of data demonstrates that babies can be exposed to signifi­
cant amounts of PBDE flame retardants both in the womb and through 
breastfeeding. Although all 3 PBDE formulations—penta, octa, and 
deca—are banned in Europe, and the penta and octa formulations were 
discontinued in the United States (deca also is banned in some states), 
PBDEs may still be used in some new U.S. products and in wares 
manufactured elsewhere. They also are found in a wide variety of older 
plastic consumer goods that remain in use in many homes, businesses, 
and automobiles. The PBDEs are known to migrate into indoor dust, 
posing a particularly high exposure risk to infants and toddlers because 
of their characteristic hand­to­mouth behavior.
To investigate how PBDEs may impact the developing fetal brain, 
the team of scientists employed a method for evaluating human devel­
opmental neurotoxicity they had recently developed [EHP 117:1131–
1138] as an alternative to animal testing. This method uses primary fetal 
human neural progenitor cells (hNPCs) cultured to produce complex 
3­dimensional cellular systems called neurospheres. Neurospheres 
undergo the same basic processes that occur during the early stages of 
normal human brain development: cell proliferation, differentiation, 
and migration. Tests conducted with neurospheres may help identify 
exogenous substances that disturb these basic processes in vivo.
The researchers focused on 2 of the PBDE compounds that accu­
mulate the most in humans, BDE­47 and BDE­99. At concentrations 
below levels that cause cell death, they found these compounds could 
reduce the migration of the hNPCs—which suggests the possi  bility 
of adverse effects on brain development—and the effects increased 
with higher PBDE concentrations. At the highest tested concentra­
tion (10 μM), BDE­47 decreased the distance the cells migrated by 
more than 25% compared with unexposed cells, whereas the same 
concentration of BDE­99 decreased the distance by more than 30%. 
Additional testing established that both compounds also interfered 
with the differentiation of immature progenitor cells into neurons and 
oligodendrocytes. 
Further tests suggested the PBDE compounds affected cell migra­
tion and differentiation by interfering with thyroid hormone signaling, 
an endocrine­disrupting effect that could be associated with addi­
tional impacts throughout a person’s life. Followup work to determine 
whether PBDEs cause the same effects in rodent neurospheres would 
facilitate extrapolation from animals to humans, the authors say.
Other work has shown the tendency of PBDEs to accumulate in 
brain and neuronal cells, and the researchers used radiolabeled BDE­47 
to measure an accumulation in test cells of approximately 60­fold. 
Considered with available human exposure data, these data suggest 
current PBDE exposure levels are likely to be of concern for human 
health, the authors write. Two recent studies have linked PBDEs with 
subtle changes in childrens’ IQs and behavior [EHP 117:1953–1958 
and EHP doi:10.1289/ehp.0901340], and the authors say additional 
studies are needed to assess these associations.
Kellyn S. Betts has written about environmental contaminants, hazards, and technology for 
solving environmental problems for publications including EHP and Environmental Science & 
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This fluorescence micrograph of 
differentiated neural progenitor 
cells shows neurons in green, glial 
cells in red, and cell nuclei in deep 
blue (the turquoise results from 
the overlay of the blue and green 
channels). 